Century Therapeutics (IPSC) Current Assets (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Current Assets data on file, last reported at $139.0 million in Q1 2026.

• On a quarterly basis, Current Assets fell 18.03% year-over-year to $139.0 million in Q1 2026; TTM through Mar 2026 was $139.0 million, a 18.03% decrease from a year earlier, with the FY2025 full-year figure at $120.8 million, down 37.76% from the prior year.
• Current Assets for Q1 2026 stood at $139.0 million, up from $120.8 million in the prior quarter.
• Over the last five years, Current Assets for IPSC reached as high as $383.8 million in Q2 2022 and fell as low as $120.8 million in Q4 2025.
• Historically, Current Assets has averaged $219.4 million across 5 years, with a median of $194.1 million in 2024.
• Across the five-year window, Current Assets jumped 40.13% in 2022 and slumped 57.98% in 2023, its largest moves.
• Year by year, Current Assets stood at $319.7 million in 2022, then slumped by 44.64% to $177.0 million in 2023, then grew by 9.64% to $194.1 million in 2024, then sank by 37.76% to $120.8 million in 2025, then gained by 15.13% to $139.0 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $139.0 million in Q1 2026, $120.8 million in Q4 2025, and $137.7 million in Q3 2025.